Publication | Closed Access
Synthesis of racemic fomannosin and illudol using a biosynthetically patterned common intermediate
44
Citations
0
References
1982
Year
Bioorganic ChemistryEngineeringAltmetric Attention ScoreSecondary MetaboliteBiosynthesisPatterned Common IntermediateNatural Product BiosynthesisRacemic FomannosinMolecular SciencesBiochemistrySocial Media PresenceDrug DevelopmentNatural Product SynthesisPharmacologyBiomolecular ScienceBiomolecular EngineeringPatterned Common IntermediatemNatural SciencesSynthetic Chemistry
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSynthesis of racemic fomannosin and illudol using a biosynthetically patterned common intermediateM. F. Semmelhack, Shuji Tomoda, Hiroto Nagaoka, Susan D. Boettger, and Kenneth M. HurstCite this: J. Am. Chem. Soc. 1982, 104, 3, 747–759Publication Date (Print):February 1, 1982Publication History Published online1 May 2002Published inissue 1 February 1982https://pubs.acs.org/doi/10.1021/ja00367a018https://doi.org/10.1021/ja00367a018research-articleACS PublicationsRequest reuse permissionsArticle Views994Altmetric-Citations40LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts